Mesoblast
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $1,578 | $1,578 | $1,257 | $1,257 |
Gross Profit | -1,701 | -1,701 | -9,581 | -9,581 |
EBITDA | -9,454 | -9,454 | -15,258 | -15,258 |
EBIT | -9,992 | -9,992 | -15,694 | -15,694 |
Net Income | -23,967 | -23,967 | -27,708 | -27,708 |
Net Change In Cash | 1,578 | 1,578 | 1,257 | 1,257 |
Free Cash Flow | -10,380 | -10,566 | -86 | -41 |
Cash | 38,029 | 38,029 | 62,563 | 62,960 |
Basic Shares | 1,142,301 | 1,142,301 | 1,121,941 | 1,121,941 |
Annual Financials
| Values in thousands | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|
Revenue | $5,902 | $7,501 | $10,211 | $7,456 |
Gross Profit | -35,168 | -47,421 | -53,361 | -78,275 |
EBITDA | -56,077 | -58,550 | -76,573 | -107,603 |
EBIT | -57,972 | -62,657 | -80,953 | -111,867 |
Net Income | -87,956 | -81,889 | -91,347 | -98,811 |
Net Change In Cash | 5,902 | 7,501 | 10,211 | 7,456 |
Free Cash Flow | -48,789 | -63,583 | -66,014 | -108,328 |
Cash | 62,563 | 70,920 | 60,034 | 136,881 |
Basic Shares | 986,702 | 839,261 | 682,861 | 605,064 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.28 |
2024-03-31 | $0 |
2023-12-31 | $0 |
2023-09-30 | -$0.13 |
